Jonathan Strober, MD, discusses advancements in pediatric myasthenia gravis, emphasizing the need for better treatment standards and effective patient care strategies.
Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis: Thousand Oaks, California Saturday, December 13, 2025, 11:00 Hrs [IST] Amgen announc ...
Regeneron is finding ways to deal with the increased competition to one of its key growth drivers. The company is also ...
Investor's Business Daily on MSN
Eli Lilly leads five stocks near buy points in divided market
Eli Lilly, United Airlines and Urban Outfitters lead five stocks that are showing strength, near buy points, as AI stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback